via Health Care https://ift.tt/Z0Yk6iT The departure of Michelle McMurry-Heath comes just as the Biden administration is poised to begin implementing key drug pricing provisions and the balance of power could shift in Congress.
'No-win situation': Pharma trade CEO steps down after clashing with board
0 Comments